Italy: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Italy

In 2021, the Italian market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -27.6% to $X, falling for the second consecutive year after three years of growth. Overall, consumption showed a abrupt descent. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Italy

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production reached $X in 2021 estimated in export price. In general, production, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2019 with an increase of 25% against the previous year. Over the period under review, production reached the maximum level in 2021 and is expected to retain growth in the near future.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports from Italy

In 2021, exports of hormones, prostaglandins, thromboxanes and leukotrienes from Italy was estimated at X tons, increasing by 4.6% against the previous year. The total export volume increased at an average annual rate of +4.8% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2014 with an increase of 21% against the previous year. Over the period under review, the exports attained the maximum in 2021 and are likely to see gradual growth in the immediate term.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports dropped to $X in 2021. Overall, total exports indicated a strong expansion from 2012 to 2021: its value increased at an average annual rate of +6.2% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2018 with an increase of 16% against the previous year. Over the period under review, the exports attained the maximum at $X in 2020, and then dropped in the following year.

Exports by Country

The United States (X tons), Brazil (X tons) and India (X tons) were the main destinations of hormones, prostaglandins, thromboxanes and leukotrienes exports from Italy, together accounting for 28% of total exports. Switzerland, Canada, Spain, Germany, Indonesia, France, Saudi Arabia, Bangladesh, the Netherlands and Turkey lagged somewhat behind, together accounting for a further 40%.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Indonesia (with a CAGR of +21.9%), while the other leaders experienced more modest paces of growth.

In value terms, the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from Italy were Switzerland ($X), the United States ($X) and Spain ($X), with a combined 35% share of total exports. These countries were followed by Germany, Brazil, India, France, Turkey, Bangladesh, Canada, the Netherlands, Indonesia and Saudi Arabia, which together accounted for a further 33%.

Saudi Arabia, with a CAGR of +18.5%, saw the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, waning by -13.9% against the previous year. Over the last nine years, it increased at an average annual rate of +1.3%. The pace of growth appeared the most rapid in 2015 when the average export price increased by 17% against the previous year. Over the period under review, the average export prices reached the maximum at $X per kg in 2020, and then contracted in the following year.

Prices varied noticeably country of destination: the country with the highest price was Spain ($X per kg), while the average price for exports to Saudi Arabia ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Switzerland (+7.3%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports into Italy

For the fourth consecutive year, Italy recorded growth in overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes, which increased by 27% to X tons in 2021. Overall, imports continue to indicate a buoyant increase. The growth pace was the most rapid in 2016 with an increase of 33% against the previous year. Imports peaked in 2021 and are likely to see gradual growth in the immediate term.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports surged to $X in 2021. In general, total imports indicated a resilient increase from 2012 to 2021: its value increased at an average annual rate of +5.9% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +84.9% against 2015 indices. The pace of growth appeared the most rapid in 2019 when imports increased by 34%. Over the period under review, imports attained the maximum in 2021 and are expected to retain growth in the near future.

Imports by Country

China (X tons), Ireland (X tons) and Belgium (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to Italy, together comprising 72% of total imports. Switzerland, France, the United States, Portugal, Germany and Mexico lagged somewhat behind, together accounting for a further 23%.

From 2012 to 2021, the biggest increases were recorded for Portugal (with a CAGR of +217.6%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to Italy, comprising 51% of total imports. The second position in the ranking was taken by Switzerland ($X), with a 23% share of total imports. It was followed by Belgium, with an 8.1% share.

From 2012 to 2021, the average annual growth rate of value from the United States amounted to +15.4%. The remaining supplying countries recorded the following average annual rates of imports growth: Switzerland (-2.9% per year) and Belgium (+0.7% per year).

Import Prices by Country

In 2021, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, reducing by -3.3% against the previous year. Over the period under review, the import price continues to indicate a deep setback. The most prominent rate of growth was recorded in 2019 an increase of 28% against the previous year. Over the period under review, average import prices hit record highs at $X per kg in 2012; however, from 2013 to 2021, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the United States ($X per kg), while the price for Portugal ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (+10.9%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :